Skip to main content

Find Clinical Trials

Home
Conditions
Relapsed/Refractory Hematologic Malignancies

Clinical trial condition

Relapsed/Refractory Hematologic Malignancies

Explore clinical trials studying Relapsed/Refractory Hematologic Malignancies. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Relapsed/Refractory Hematologic Malignancies trial results

Not yet recruiting

Dose-Escalation/Expansion Study of iMagic in Relapsed/Refractory Hematologic Malignancies

NCT07802756

Conditions: Hematologic Diseases, Hematologic Neoplasms, Hemic and Lymphatic Diseases, +3 more
Locations: National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, China

View Trial Details

Not yet recruiting

A Multicenter, Open-label, Non-randomized, Single-arm Phase 1/2 Study of Autologous Nano CD5-CAR T Cells for the Treatment of Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia/Lymphoma

NCT07678307

Conditions: Hematologic Diseases, Hematologic Neoplasms, Hemic and Lymphatic Diseases, +14 more
Locations: Not specified

View Trial Details